Lundbeck
HLUN-B.CO
#2637
Rank
C$8.90 B
Marketcap
C$9.38
Share price
-0.18%
Change (1 day)
15.53%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): C$0.85

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$0.84. In 2024 the company made an earnings per share (EPS) of C$0.61 an increase over its 2023 EPS that were of C$0.47.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.8539.77%
2024C$0.6129.29%
2023C$0.4723.09%
2022C$0.3837.26%
2021C$0.28-84.61%
2020C$1.81-24.61%
2019C$2.40-42.06%
2018C$4.1540.7%
2017C$2.95146.26%
2016C$1.20-120.48%
2015C-$5.843231.32%
2014C-$0.18-115.78%
2013C$1.11-23.36%
2012C$1.45-48.01%
2011C$2.79-9.68%
2010C$3.0913.72%
2009C$2.7224.32%
2008C$2.18-6.05%
2007C$2.3381.77%
2006C$1.28-16.76%
2005C$1.54-17.58%
2004C$1.86